Date(s) - November 13, 2017
12:00 PM - 1:00 PM
On Monday, November 13th, The Life Raft Group in collaboration with Deciphera Pharmaceuticals hosted a webcast to provide patients with an overview of the DCC-2618 GIST program, including enrollment updates from the ongoing phase 1 trial, reviewed key clinical data and provided details on the upcoming Phase 3 registration trial for the treatment of patients who have received at least 3 prior therapies. The webcast closed with a Q&A.
The webcast was held on Monday, November 13, 2017 beginning at 12:00 p.m., Eastern Time (9:00 a.m., Pacific Time).
Oliver Rosen, MD, Chief Medical Officer and Jama Pitman, VP Regulatory Affairs and Quality, both of Deciphera Pharmaceuticals, will be presenting.
Oliver Rosen, MD